Gastric cancer characteristics and care patterns in Algeria
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria
Société Algérienne de Formation et Recherche en Oncologie · NCT07481110
This project collects medical records and short interviews to describe who has gastric cancer and how they are diagnosed and treated at Algerian oncology centers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Société Algérienne de Formation et Recherche en Oncologie (other) |
| Locations | 15 sites (Algiers, Algeria and 14 other locations) |
| Trial ID | NCT07481110 on ClinicalTrials.gov |
What this trial studies
This is a non-interventional, descriptive, cross-sectional study using both retrospective and prospective data collection. It seeks to characterize the demographic, epidemiological, clinical, diagnostic, and therapeutic features of about 1,000 patients with histologically confirmed gastric carcinoma in Algeria. Data come from hospital medical records and brief (≈30-minute) patient interviews, with all information anonymized for research use. No experimental treatments are given; the study documents current diagnostic and management practices at participating oncology departments.
Who should consider this trial
Good fit: Adults aged 19 or older with a histologically confirmed gastric carcinoma who are followed at one of the participating Algerian oncology departments and can give informed consent.
Not a fit: Patients with non-carcinoma stomach tumors (for example GIST, lymphoma, or sarcoma), secondary gastric tumors, those under 19, or people enrolled in interventional studies are unlikely to benefit from this observational project's findings.
Why it matters
Potential benefit: If successful, the results could help clinicians in Algeria detect gastric cancer earlier and make better-informed treatment decisions for patients.
How similar studies have performed: Similar national and international observational registries have successfully clarified patterns of gastric cancer and informed care, though Algeria-specific data have been limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 19 years and older * Histologically confirmed diagnosis of gastric cancer * Patients followed in the participating oncology departments * Informed consent obtained Non Inclusion Criteria: * Histological types other than carcinoma (e.g., GIST, lymphoma, sarcoma, etc.). * Secondary gastric tumors * Participation in an interventional study
Where this trial is running
Algiers, Algeria and 14 other locations
- Cac Blida — Algiers, Algeria, Algeria (NOT_YET_RECRUITING)
- CHU Béni Messous — Algiers, Algeria, Algeria (RECRUITING)
- CPMC — Algiers, Algeria (NOT_YET_RECRUITING)
- EPH Rouiba — Algiers, Algeria (NOT_YET_RECRUITING)
- CHU Annaba — Annaba, Algeria (NOT_YET_RECRUITING)
- CHU Constantine — Constantine, Algeria (NOT_YET_RECRUITING)
- EPH Constantine — Constantine, Algeria (NOT_YET_RECRUITING)
- CAC Oued Souf — El Oued, Algeria (NOT_YET_RECRUITING)
- CAC Oran — Oran, Algeria (NOT_YET_RECRUITING)
- CHU Oran — Oran, Algeria (NOT_YET_RECRUITING)
- EHU Oran — Oran, Algeria (NOT_YET_RECRUITING)
- CAC Sétif — Sétif, Algeria (NOT_YET_RECRUITING)
- CAC Sidi Bel Abbès — Sidi Bel Abbes, Algeria (NOT_YET_RECRUITING)
- EPH Sidi Ghiles — Tipasa, Algeria (NOT_YET_RECRUITING)
- CAC DBK — Tizi Ouzou, Algeria (NOT_YET_RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Gastric Cancer, Gastric cancer in Algerian patients, Observational study, Patient outcomes, Oncology, Retrospective data, Treatment strategies, Diagnostic approaches